[Federal Register Volume 83, Number 152 (Tuesday, August 7, 2018)]
[Notices]
[Pages 38718-38719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16790]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases 
Notice of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the National Diabetes 
and Digestive and Kidney Diseases Advisory Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council.
    Date: September 7, 2018.
    Open: 8:30 a.m. to 12:00 p.m.
    Agenda: To present the Director's Report and other scientific 
presentations.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Closed: 1:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Karl F. Malik, Ph.D., Acting Director, Division 
of Extramural Activities, National Institutes of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 
5452, Bethesda, MD 20892, (301) 594-4757, [email protected].

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Kidney, Urologic and Hematologic Diseases 
Subcommittee.
    Date: September 7, 2018.
    Open: 1:00 p.m. to 2:45 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 7, 31 Center Drive, Bethesda, MD 20892.
    Closed: 2:45 p.m. to 3:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 7, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Karl F. Malik, Ph.D., Acting Director, Division 
Of Extramural Activities, National Institutes of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 
5452, Bethesda, MD 20892, (301) 594-4757, [email protected].

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Diabetes, Endocrinology, and Metabolic 
Diseases Subcommittee.
    Date: September 7, 2018.
    Open: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Closed: 2:00 p.m. to 3:15 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Karl F. Malik, Ph.D., Acting Director, Division 
Of Extramural Activities, National Institutes of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 
5452, Bethesda, MD 20892, (301) 594-4757, [email protected].

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Digestive Diseases and Nutrition 
Subcommittee.
    Date: September 7, 2018.
    Open: 1:00 p.m. to 2:00 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Closed: 2:15 p.m. to 3:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Karl F. Malik, Ph.D., Acting Director, Division 
of Extramural Activities, National Institutes of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 
5452, Bethesda, MD 20892, (301) 594-4757, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

[[Page 38719]]

    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm., 
where an agenda and any additional information for the meeting will 
be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: August 1, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-16790 Filed 8-6-18; 8:45 am]
 BILLING CODE 4140-01-P